Global Trends in R&D 2024 is an annual trend report from the IQVIA Institute that assesses the trends in new drug launches and the overall number of initiated clinical trials, the state of R&D funding, the acceleration and adaptability of the innovation
This video looks at highlights from the IQVIA Institute report on Global Trends in R&D 2023, including new drug approvals and the industry's pipeline of medicines in clinical development in addition to clinical trial activity, clinical development produc
In this Applied Clinical Trials video interview, Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses findings from IQVIA's Global Trends in R&D 2024 report. IQVIA's Global Trends in R&D 2024 Report Video Player is loading. This is a modal window. This ...
导读近日,IQVIA Institute发布年度重磅报告Global Trends in R&D: Overview through 2021,报告对2021年 全球新药上市情况、研发管线布局、临床试验活动、临床开发生产力等进行了全景回顾。根据报告,尽管仍…
$泽生科技(SZ871392)$日前,IQVIA人类数据科学研究所(IQVIA Institute for Human Data Science)发布了关于2024年全球生物医学产业研发的研究报告(Global Trends in R&D2024)。其中的数据分析显示,随着整体研发资金的增加、临床试验于特定领域的增长、研发效率的提高与创新药物获批数量增加,全球生物医药行业正展现出复苏和增...
Institute Report Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios This report from the IQVIA Institute reflects on the current state of the end-to-end environment for cell and gene therapies Institute Report Global Trends in R&D 2024: Activity, productivity, an...
Global Trends in R&D 2024: Activity, productivity, and enablers learn more Long-term Market Sustainability for Infused Biosimilars in the U.S. learn more Trends in Adult Vaccination in the U.S. Learn more The Global Use of Medicines 2024: Outlook to 2028 ...
Institute Report Global Oncology Trends 2024: Outlook to 2028 Learn more Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios Learn more Global Trends in R&D 2024: Activity, productivity, and enablers Learn more ...
Building a predictive algorithm for early Alzheimer's detection requires deep domain expertise in epidemiology and disease progression, alongside unparalleled non-identified data from diverse sources beyond EMRs. It also needs advanced analytics and a well-trained machine learning system. This is Human Da...
Institute Report Global Trends in R&D 2022 Overview through 2021 Institute Report The Global Use of Medicines 2022 Outlook to 2026 Institute Report Valuing the Research-based Pharmaceutical Industry in Latin America Assessing the economic & societal footprint ...